Navigation Links
nanoTox COO Greg King Advises Nanotech Companies to View Safety Concerns as an Opportunity to Gain Consumer Trust

nanoTox COO Greg King responded to the AOL News series, “The Nanotech Gamble,” with advice for nano-product companies on how to turn concerns over nanotechnology into consumer relations wins.

Austin, TX (Vocus) -- Responding to a series of AOL News articles questioning the oversight of nanotechnology product safety (, nanoTox COO Greg King said that nano-product companies will need to confront possible negative perceptions directly to avoid the kinds of public outcry experienced by bioengineered food companies in the past.

“It’s in people’s nature to fear the unknown,” said King. “And while companies may not be able to educate everyone in the complexities of nanotechnology, they can turn safety concerns to their advantage by being transparent about its use in their products, documenting their careful research and emphasizing concern over human and environment health.”

King was responding to AOL News and Pulitzer Prize-winning reporter Andrew Schneider, who published a series entitled “The Nanotech Gamble” which explored possible risks that may accompany nanotechnology research and product development. Schneider’s series was greeted with concern by most in the U.S. nanoproduct industry.

“Schneider’s articles expresses quite well the public’s concern about nanomaterials.” King added. “No new technology gains wide consumer acceptance until potential safety concerns are addressed and resolved.

“Companies wanting to successfully commercialize products that contain nanomaterials will need to address those safety concerns. This is especially true for nanoproducts that have direct human contact, such as textiles, foods, medicines, cosmetics, personal care products. The companies that can demonstrate that their products are safe will have a competitive advantage.”

King is the author of several articles on nanotechnology risk management and nanotechnology regulation. King’s company, nanoTox, is the first to provide complete risk assessment and solutions exclusively for nanoparticles.

“The nanotech revolution is one of the best opportunities for cosmetic, food, and other companies incorporating nanoparticles to build new trust with their existing and future customers,” said King. “By showing that they are ahead of the game, they can inoculate themselves against negative perceptions and even champion themselves as leaders in product safety.”

About nanoTox™, Inc.
nanoTox is the first company to provide complete risk assessment – and solutions – exclusively for nanoparticles. nanoTox can help companies commercialize their products by helping address safety issues and responding to regulatory requirements.

nanoTox determines the toxicity of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, litigation and for acceptance by the insurance industry.

nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability. For more information, visit


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Burrill Merchant Banking Advises NPS on Phase III Licensing Agreement
2. Burrill Merchant Banking Advises Faes Farma on Bilastine Licensing Agreement
3. White Paper Advises Pharma Manufacturers on How to Select an Aseptic Fill/Finish Contractor, Avoid the Most Common Mistakes
4. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
5. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
6. KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd
7. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
8. NASA technology forms the basis for a new nanotechnology company
9. Superbugs, shapes and nanotechnology
10. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
11. Nanotech could make solar energy as easy and cheap as growing grass
Post Your Comments:
(Date:10/8/2015)... MANASSAS, Va. , Oct. 8, 2015  ATCC, ... announces today that it has been selected by The ... provide vital cell lines to academic, pharmaceutical, and biotechnology ... the United States , ... --> the United States , ...
(Date:10/8/2015)... October 8, 2015 Global ... Global Biologics and Biosimilars industry . --> ... Biologics and Biosimilars Industry 2015 Deep Market Research ... is a professional and depth research report on ... ) , --> ...
(Date:10/8/2015)... 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, today announced its ... taking place in the month of October: ... RepliCel will be presenting at the annual Partnering ... Mesa to be held October 7-9 in ...
(Date:10/8/2015)... ... October 08, 2015 , ... ProMIS Neurosciences, Inc. ... to develop and commercialize intellectual property rights belonging to The University of British ... and affords exclusive worldwide rights to intellectual property based on use of the ...
Breaking Biology Technology:
... Commercialization and Supply Agreement, Company to Host Conference Call at 12:30 p.m. ... ... 2007, LEXINGTON, Mass., Sept. 19 Indevus,Pharmaceuticals, Inc. (Nasdaq: ... acquisition of Esprit Pharma, has obtained the,United States rights to SANCTURA(R) and ...
... Ventures, Kleiner Perkins ... Ventures, Strong Endorsement of Technology Pioneer at Forefront of Developing No- ... Compromise Biofuels, ... renewable hydrocarbon biofuels, today,announced that it closed the first tranche of its $70 ...
... - IDF Launches New Guideline for the ... the new global guideline for diabetes care which,includes ... people with diabetes should have their blood glucose ... diabetes control and reduce the,risk of complications, particularly ...
Cached Biology Technology:
(Date:9/24/2015)... September 24, 2015 ... 2015 Kerv ( ... lanserar idag världens första kontaktlösa betalningsring på ... 77 000 GBP för massproduktion via crowdfunding.  ... ) , Kerv-bärare kan göra ...
(Date:9/10/2015)... , Sept. 10, 2015 Pursuant Health ... Wellness to create an interactive, image-based health risk ... and wellness kiosk.  The unique assessment quantifies user ... number that suggests an individual,s biological age based ... as measured by the kiosk. Comprised ...
(Date:9/8/2015)... BOSTON , Sept. 8, 2015  Affectiva, ... of Emotion as a Service, a new data ... Based on Affectiva,s highly accurate and ... and analytics capabilities, slated to transform industries such ... app development, retail, customer experience, online education, HR, ...
Breaking Biology News(10 mins):
... For the first time, researchers have been able to confine ... role in photosynthesis, without having to pin it down so ... first practical application to proteins of a recently developed technique, ... the dynamic behavior of the molecule for more than one ...
... system science disciplines recently gathered to address a major ... future? Of course, possible answers to this question ... conditions were to alter local vegetation, how would this ... questions with certainty would allow us to manage better ...
... , SEATTLE, WA March 10, 2010 -- The ... genome sequences of a human family of four. The findings ... the University of Luxembourg was published online today by Science ... benefit of sequencing entire families, including lowering error rates, identifying ...
Cached Biology News:
... 27kDa periplasmic enzyme from E. coli that ... nucleotide monophosphate (NMP) intermediates. Slower hydrolysis further ... 3-NMPs (1). RNase ONE Ribonuclease is one ... cleave a phosophodiester bond between any two ...
... Rabbit polyclonal to Dideoxycytidine Dideoxycytidine is ... be effective in inhibiting retroviral activity. ... BSA. Specificity: The specificity of ... ratio of the moles of ddC to moles ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
... MSC series of Class II Biological ... and certification to the world's highest ... that the cabinets cannot be adjusted ... lighting, low noise and arm rest ...
Biology Products: